Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
Photovoltaic
Grid/power transmission
Digital technology for carbon accounting and consulting
| No. | Sectors | Company invested |
|---|---|---|
| 1 | Photovoltaic |
|
| 2 | Grid/power transmission |
|
| 3 | Digital technology for carbon accounting and consulting |
|
| No. | Investment Date | Investment Round | Investment Amount | Company invested |
|---|---|---|---|---|
| 1 | 2022-07-18 | B+ round | 亿级人民币 | Immuno-tech |
| 2 | 2022-03-29 | B++ round | 200 million RMB | Bio-engine |
| 3 | 2022-03-07 | translation missing: en.rounds.Pre-A轮 | undisclosed | Jinkebo Biotechnology |
| 4 | 2022-01-29 | translation missing: en.rounds.A轮 | $40 million | Dansheng Pharmaceutical |
| 5 | 2021-12-30 | B+ round | Over RMB200 million | Shangjian Biotechnology |
